Analyst firms · Raymond James · WVE

Raymond James WVE price target and rating history

Wave Life Sciences Inc. (WVE) · Health Care

Raymond James rates Wave Life Sciences Inc. (WVE) Outperform with a $14 price target, as of its latest action on Jun 11, 2025. It has published 3 rating actions on WVE since July 2023, including 1 upgrade and 0 downgrades. Across 6 firms with a WVE price target in the last 12 months, the median target is $21.

Current rating
Outperform
Price target
$14
Median target, all firms
$21
Actions on WVE
3

Raymond James price target on WVE

$22$15$7202420252026
Raymond James price target on WVE, each point a stated target, July 2023 to June 2025.

Every Raymond James rating on WVE

How other firms rate WVE

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
William BlairOutperformOct 16, 2026
UBSBuy$11Oct 15, 2026
Ladenburg ThalmannBuy$10Oct 1, 2026
Truist SecuritiesBuy$15Apr 29, 2026
BofA SecuritiesBuy$38Feb 5, 2026
WedbushOutperform$33Dec 12, 2025
RBC Capital MarketsOutperform$27Dec 9, 2025

Questions about Raymond James and WVE

What is Raymond James's price target for WVE?
Raymond James's latest stated price target for Wave Life Sciences Inc. (WVE) is $14, from its action on Jun 11, 2025.
What is Raymond James's rating on WVE?
Raymond James rates WVE Outperform, a bullish rating, as of Jun 11, 2025.
When did Raymond James last change its view on WVE?
On Jun 11, 2025, Raymond James resumes coverage at Outperform, price target $14.
How does Raymond James's WVE target compare with other analysts?
Across 6 firms with a WVE price target in the last 12 months, the median target is $21.

All Raymond James ratingsWVE news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.